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Abstract
Elevated H2O2 is implicated in many cardiovascular diseases. We previously
demonstrated that H2O2-induced endothelial nitric oxide synthase (eNOS) acti-
vation and excessive NO production contribute to vascular cell injury and
increases in microvessel permeability. However, the mechanisms of excessive
NO-mediated vascular injury and hyperpermeability remain unknown. This
study aims to examine the functional role of NO-derived peroxynitrite
(ONOO) in H2O2-induced vascular barrier dysfunction by elucidating the
interrelationships between H2O2-induced NO, superoxide, ONOO
, and
changes in endothelial [Ca2+]i and microvessel permeability. Experiments were
conducted on intact rat mesenteric venules. Microvessel permeability was deter-
mined by measuring hydraulic conductivity (Lp). Endothelial [Ca2+]i, NO, and
O2
 were assessed with fluorescence imaging. Perfusion of vessels with H2O2
(10 µmol/L) induced marked productions of NO and O2
, resulting in exten-
sive protein tyrosine nitration, a biomarker of ONOO. The formation of
ONOO was abolished by inhibition of NOS with NG-Methyl-L-arginine.
Blocking NO production or scavenging ONOO by uric acid prevented H2O2-
induced increases in endothelial [Ca2+]i and Lp. Additionally, the application of
exogenous ONOO to microvessels induced delayed and progressive increases
in endothelial [Ca2+]i and microvessel Lp, a pattern similar to that observed in
H2O2-perfused vessels. Importantly, ONOO
 caused further activation of eNOS
with amplified NO production. We conclude that the augmentation of NO-
derived ONOO is essential for H2O2-induced endothelial Ca
2+ overload and
progressively increased microvessel permeability, which is achieved by self-pro-
moted amplifications of NO-dependent signaling cascades. This novel mecha-
nism provides new insight into the reactive oxygen and/or reactive nitrogen
species-mediated vascular dysfunction in cardiovascular diseases.
Introduction
Increased production of reactive oxygen species (ROS)
has been demonstrated to cause impaired vascular barrier
function, resulting in tissue damage and organ dysfunc-
tion (Del Maestro et al., 1981; Cai and Harrison, 2000;
Zhu and He, 2006; Zhou et al., 2009; Di et al., 2016;
Mundi et al., 2017). Our previous studies demonstrated
that hydrogen peroxide (H2O2) at a pathophysiologcally
relevant concentration (10 lmol/L) induced delayed and
progressive increases in endothelial calcium concentration
(EC [Ca2+]i) and microvessel permeability that was attrib-
uted to H2O2-induced excessive nitric oxide (NO) pro-
duction through endothelial nitric oxide synthase (eNOS)
activation (Zhou et al., 2013).
While physiological levels of NO have been recognized
to be essential for the maintenance of many vascular
functions, excessive NO has been demonstrated to play
important roles in mediating inflammation-induced vas-
cular leakage (Yuan et al., 1993; He et al., 1997; Zhu and
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He, 2005; Hatakeyama et al., 2006; Zhou and He, 2010;
Zhou and He, 2011; Mundi et al., 2017). Our previous
studies demonstrated that, instead of causing immediate
and transient increases in microvessel permeability as
observed in inflammatory mediator-stimulated vessels
(He et al., 1996; Baluk et al., 1997; Zhu and He, 2005;
Jiang et al., 2008; Zhou and He, 2011), large amounts of
H2O2-induced NO production resulted in caspase activa-
tion and impairment of Ca2+ homeostasis, leading to vas-
cular cell apoptosis, and delayed and progressive increases
in microvessel permeability (Zhou et al., 2013).
Exogenously supplied NO has been reported to have
potential cytotoxic effects in cultured endothelial cells
(Shen et al., 1998; Shimizu et al., 1998). However, the
mechanisms of NO-mediated vascular cell injury, particu-
larly in H2O2-stimulated intact vessels remain unknown.
Accumulating evidence suggest that the cytotoxic effects of
NO are most likely mediated by its oxidation product, par-
ticularly peroxynitrite (ONOO), rather than NO itself
(Xia et al., 1996; Riobo et al., 2001; Pacher et al., 2007). NO
reacts rapidly with superoxide (O2
) at a diffusion-con-
trolled rate (~1 9 1010 M1 s1) to form ONOO, a
strong oxidant capable of oxidizing and nitrating lipid, pro-
tein, and DNA, resulting in cell death and tissue injury
(Radi et al., 1991; Pacher et al., 2007; Szabo et al., 2007).
Recently, H2O2 has been shown to induce further produc-
tion of O2
 and H2O2 mainly through activation of NAD
(P)H oxidase (Li et al., 2001; Cai, 2005), which is consid-
ered as an important mechanism for ROS-mediated patho-
genesis of cardiovascular diseases. However, whether the
interplay between reactive oxygen species, nitric oxide, and
peroxynitrite is accountable for H2O2-induced microvessel
barrier dysfunction remains unknown.
Currently, the role of ONOO in the regulation of
eNOS activity and NO production, particularly under
in vivo conditions, has not been well defined. While some
early studies reported that ONOO induced vasodilation
through increased NO production (Liu et al., 1994; Villa
et al., 1994), others on cultured bovine endothelial cells
suggested that, although ONOO increased eNOS activity
through enhanced phosphorylation at Ser1179, it increased
O2
 production, instead of NO (Zou et al., 2002; Zou
et al., 2002). The interrelationship between ONOO and
eNOS activity and their roles in the regulation of vascular
barrier function in intact vessels has not been well
explored.
This study is designed to examine the functional roles
of ONOO in H2O2-induced microvessel barrier dysfunc-
tion by elucidating the interrelationships between H2O2,
eNOS-derived NO, O2
, ONOO, and the changes in EC
[Ca2+]i and microvessel permeability. Experiments were
conducted on individually perfused mesenteric venules
with intact surrounding circulation. EC [Ca2+]i and NO
were measured in Fura-2 and DAF-2-loaded vessels,
respectively. Microvessel permeability was determined by
measuring hydraulic conductivity (Lp). We first measured
H2O2-induced changes in EC [Ca
2+]i, NO production,
and microvessel Lp. Under the same experimental condi-
tions, H2O2-induced O2
 production was assessed using
dihydroethidium. The formation of ONOO was exam-
ined by fluorescent immunostaining of nitrotyrosine, a
biomarker of ONOO, in H2O2-perfused vessels. The
functional relationship between ONOO, and changes in
EC [Ca2+]i and microvessel permeability was further
investigated using uric acid, an endogenous ONOO
scavenger. The direct effects of exogenously applied
ONOO on EC [Ca2+]i, NO production, as well as
microvessel Lp, were also examined.
Materials and Methods
Animal preparation
All animal experiments were conducted on female
Sprague–Dawley rats (2–3 months old, 220–250 g; Hilltop
Laboratory Animal, Scottdale, PA). All procedures and
animal use were approved by the Animal Care and Use
Committee at West Virginia University. Rats were anes-
thetized with pentobarbital sodium (65 mg/kg body wt)
administered subcutaneously. A midline surgical incision
(1.5–2 cm) was made in the abdominal wall and the
mesentery was gently taken out from the abdominal cav-
ity and spread over a glass coverslip attached to an animal
tray for studies. The upper surface of the mesentery was
continuously superfused with mammalian Ringer’s solu-
tion at 37°C. Each experiment was performed on one
microvessel per animal.
Measurement of Lp in individually perfused
rat mesenteric microvessels
Microvessel permeability was assessed by measuring
hydraulic conductivity, Lp, using modified Landis tech-
nique, which measures the volume flux of water across
the microvessel wall. Details have been described previ-
ously (Curry and Sarelius, 1983; Kendall and Michel,
1995; He et al., 1996). Briefly, a single venular microvessel
with diameters ranging between 35 and 50 lm was can-
nulated with a micropipette and perfused with albumin-
Ringer solution (control) containing 1% (vol/vol) hamster
red blood cells as markers. A known hydrostatic pressure
(40–60 cmH2O), controlled by a water manometer, is
applied through the micropipette to the vessel lumen,
which allows the perfusate to continuously flow through
the vessel. For each measurement, the perfused vessel was
occluded briefly downstream with a glass rod. The initial
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water flux/unit area of microvessel wall (Jv/A) was calcu-
lated from the velocity of the marker cell after vessel occlu-
sion, the vessel radius, and the distance between the
marker cell and the occlusion site. Lp was calculated as the
slope of the relationship between Jv/A and the pressure dif-
ference across the vessel wall. In each experiment, the base-
line Lp and the Lp after the application of testing solutions
were measured in the same vessel, and the changes in Lp
were expressed as the ratio of Lptest/Lpcontrol. All testing
agents were added to the perfusate and delivered into the
vessel lumen through the cannulation pipette. To prevent
the marker red blood cells from interacting with H2O2 and
ONOO in the perfusate, marker cells were absent during
the perfusion period and added back for Lp measurements
after designated duration of perfusion.
Measurements of EC [Ca2+]i
EC [Ca2+]i was measured in individually perfused
microvessels using the fluorescent Ca2+ indicator fura 2-
AM. Experiments were performed on a Nikon Diaphod
300 microscope equipped with a Nikon photometry sys-
tem. In each experiment, a venular microvessel was can-
nulated and perfused first with albumin-Ringer solution
that contained 10 µmol/L of fura 2-AM for 45 min. The
vessel was then recannulated and perfused with albumin-
Ringer solution for 10 min to remove fura 2-AM from
the vessel lumen. A segment of fura 2-AM-loaded vessel
at least 100 µm away from the cannulation site was then
positioned within the measuring window which cov-
ered ~50 ECs forming the vessel wall. The excitation
wavelengths for fura 2-AM were selected by two narrow-
band interference filters (340  5 and 380  5 nm;
Oriel), and the emission was separated with a dichroic
mirror (DM400) and a wide-band interference filter
(500  35 nm; Oriel). The corresponding FI values (FI340
and FI380, respectively) were collected with a 0.25-sec
exposure at each wavelength. Baseline EC [Ca2+]i was
measured after fura 2-AM was removed from the vessel
lumen with albumin-Ringer perfusion for 10 min. Then
the same vessel was recannulated with pipette containing
test reagents (e.g., H2O2, ONOO
, L-NMMA, uric acid,
LaCl3, etc.) and the changes in EC [Ca
2+]i were measured
immediately after the recannulation. At the end of the
experiment, the microvessel was superfused with a modi-
fied Ringer solution (5 mmol/L of Mn2+ without Ca2+)
and perfused with the same solution that contained iono-
mycin (10 µmol/L) to bleach the Ca2+-sensitive form of
fura 2. The background FI due to unconverted fura 2-AM
and other Ca2+-insensitive forms of fura 2 were sub-
tracted from FI340 and FI380 values. The ratios of the two
FI values were converted to Ca2+ concentrations using an
in vitro calibration curve (He et al., 1996).
Measurement of endothelial NO production
Levels of endothelial NO were quantified at cellular level
in individually perfused microvessels using a fluorescence
imaging system and 4,5-diaminofluorescein diacetate
(DAF-2 DA). The experimental rigs were the same as
that used for Ca2+ measurements, except that a 12-bit
digital, cooled, charge-coupled device camera (ORCA;
Hamamatsu) was used for image acquisition. The excita-
tion wavelength for DAF-2 DA was selected by an inter-
ference filter (480/40 nm), and emission was separated
by a dichroic mirror (505 nm) and a band-pass barrier
(535/50 nm). To minimize photo bleaching, a neutral
density filter (0.5 N) was positioned in front of the
interference filter and the exposure time was minimized
to 0.12 sec at 1-min intervals. All the images were
acquired and analyzed using Metafluor software (Univer-
sal Imaging). During the experiment, each vessel was
continuously perfused with albumin-Ringer solution
containing DAF-2 DA (5 µmol/L). NO production was
measured after the DAF-2 loading reached the steady
state (Zhou and He, 2011). Basal NO was measured for
10 min before perfusion with test reagents. All images
were collected from a group of ECs located at the same
focal plane of the vessel wall. At the end of the experi-
ment, the NO donor, sodium nitroprusside (SNP,
50 mmol/L) was applied to the superfusate to ensure
sufficient intracellular DAF-2 to react with NO. Quanti-
tative analysis was conducted at the individual EC level
using manually selected regions of interest (ROIs) along
the vessel wall. Each ROI covers the area of one individ-
ual EC as indicated by the fluorescence outline. The tis-
sue autofluorescence was subtracted from all the
measured FIs. The changes in FIDAF upon addition of
test reagents were expressed as the percentage of FIDAF
over the baseline FI0 (FI/FI0*100). The rate of FIDAF
change was derived by the first differential conversion of
cumulative FIDAF over time. DAF-2 specificity for NO
detection was examined by mixing DAF-2 (10 µmol/L)
with albumin-Ringer solution, H2O2 (5, 50 and
500 µmol/L), SNP (20 and 200 µmol/L), hypoxanthine/
xanthine oxidase (0.05 mmol/L /1 mU, 0.5 mmol/L /
10 mU, and 5 mmol/L /100 mU), or peroxynitrite (5,
50, and 500 µmol/L) using the same experimental set-
tings as those used for NO measurement on intact ves-
sels. No significant increase in FIDAF-2 was observed for
all the test agents except SNP at 200 µmol/L that caused
an accumulative increase in FIDAF-2, indicating the speci-
ficity of DAF-2 as a NO fluorescent indicator. Peroxyni-
trite at 500 µmol/L caused a small increase in FIDAF, but
that concentration is beyond the range we used in the
experiments. The representative measurements with each
agent are shown in Fig 1.
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Confocal images of fluorescent
immunostaining for nitrotyrosine and
superoxide detection
Leica confocal system (SP2) was used to detect fluores-
cent immunostaining for nitrotyrosine and superoxide
production with dihydroethidium (DHE) in H2O2-per-
fused vessels. Images were acquired using Leica objec-
tive 963 (HCX PL APO, NA 1.2) with 91.5 electronic
zoom, and the vertical step was 0.3 lm. The mean FI of
each stack of ROIs that cover the vessel wall was
quantified using Leica confocal software. The averaged FI
of the perfused vessels was calculated. The ratio of the FI
over control value was used to present the changes in the
nitrated tyrosine content. The absolute mean FI in arbi-
trary unit from each vessel was calculated for DHE
images to semi-quantify the magnitude of superoxide
production. Nitrotyrosine immunostaining was conducted
in fixed vessels. The mesentery bearing each perfused ves-
sel was fixed with paraformaldehyde, followed by 10-min
permeabilization with 0.1% Triton X-100 and 1 h block-
ing with 5% bovine serum before overnight exposure to
the mouse Anti-Nitro tyrosine antibody (ab7048, abcam,
USA) at 4°C on an automatic laboratory shaker. The tis-
sue was then washed with BSA-Ringer solution for three
times before incubation with Alexa 488-conjugated goat
anti-mouse secondary antibody (ab150113, abcam, USA)
at room temperature for 3 h. For detection of superoxide,
each vessel was loaded with DHE (10 µmol/L) for 30 min
followed by perfusion with either BSA-Ringer alone or
containing H2O2 (10 µmol/L) for 30 min. The images
were acquired with excitation at 488 nm and emission at
590–700 nm. To determine the source of superoxide,
diphenylene iodonium (DPI, an NADPH oxidase inhibi-
tor, 20 µmol/L) was applied to the vessel for 20 min after
DHE loading, followed by perfusion with H2O2
(10 µmol/L) in the presence of DPI.
Solutions and reagents
Mammalian Ringer solution (He et al., 1996) was used
for dissecting mesenteries, superfusing tissues, and prepar-
ing perfusion solutions. The composition of the mam-
malian Ringer solution was (in mmol/L) 132 NaCl, 4.6
KCl, 2 CaCl2, 1.2 MgSO4, 5.5 glucose, 5.0 NaHCO3,
20 N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid
(HEPES), and Na-HEPES. All perfusates used for control
and test perfusion contained BSA (10 mg/ml). Fura-2 AM
was purchased from Invitrogen. H2O2 (30%), DAF-2,
DAF-2 DA, LaCl3, L-NMMA, DPI, and DHE were pur-
chased from Sigma. All the fluorescent dyes except for
Alexa488-conjugated secondary antibody (in BSA-Ringer
solution) were prepared in DMSO for stock solution, and
at least 1:1000 dilution was made for the final working
solutions. ONOO and degraded ONOO were pur-
chased from EMD Millipore and were diluted in the
BSA-Ringer solution into final concentrations of 10 or
50 µmol/L. All perfusates containing the test reagents
were freshly prepared before each cannulation.
Data analysis and statistics
All values are presented as means  SD. Each “n” repre-
sents the number of vessels (one vessel per rat). Paired
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Figure 1. DAF-2 specificity as NO indicator. To examine the
specificity of DAF-2 for NO, we conducted in vitro experiments to
assess the direct reaction of DAF-2 with H2O2, superoxide
(generated by hypoxanthine/xanthine oxidase system, HX/XO),
peroxynitrite (PRX), and NO donor sodium nitroprusside (SNP) at
variable concentrations over 20-min reaction time. Each reagent
was individually added to BSA-Ringer solution containing DAF-2
(10 µmol/L), and the changes in DAF FI were recorded immediately
using the same imaging system where NO was measured in intact
microvessels. All FI measurements were acquired using identical
settings. A and B show one set of measurements and triplet
measurements were collected with each reagent. No significant
changes in FIDAF were found, except with NO donor, SNP at
200 µmol/L, and peroxynitrite at 500 µmol/L, suggesting that DAF-
2 does not directly interact with ROS and peroxynitrite in the
absence of NO within the reagents’ concentrations we used in the
experiments
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t-test was used for paired data analysis, that is, control and
treatment were conducted in the same vessel. Unpaired t-
test with Welch’s correction was used for data comparison
between two groups, and one-way or two-way ANOVA
with Tukey post hoc test was applied for multiple group
comparison. A probability value of P < 0.05 was consid-
ered as statistically significant, and the exact or the range of
p values is presented in figure legends.
Results
H2O2 induced NO-dependent increases in
microvessel Lp and EC [Ca2+]i
We previously demonstrated that H2O2 at pathologically
relevant concentrations induced delayed and progressive
increases in microvessel Lp, which was initiated by the acti-
vation of eNOS and excessive NO production (Zhou et al.,
2009; Zhou et al., 2013). Fig 2A shows the summary results
of H2O2-induced time- and dose-dependent increases in
Lp. The H2O2-induced endothelial NO production was
measured in DAF-2 DA-loaded venules. Fig 2B shows the
time course of H2O2-induced NO production (presented
as the mean changes in FIDAF-2 pooled from four vessels).
Since the FIDAF increase in reaction to NO is cumulative
(irreversible chemical conversion), the greater slope of the
FIDAF increase indicates a higher NO production rate and
the plateau indicates no further increase in NO. When
H2O2 (10 µmol/L) was perfused into the microvessel, there
was an immediate increase in FIDAF that reached
425  18.1% of the baseline level in 5 min, followed by a
lower sustained level. A second increase in FIDAF was
observed after 20 min of H2O2 perfusion with 280  41%
additional increase in FIDAF, and reached a plateau level at
41 min of H2O2 perfusion with a total of 830  85%
increase in FIDAF. In another four DAF-2 DA-loaded ves-
sels, perfusion of albumin-Ringer solution as a control
showed approximately 1% increase per minute in FIDAF,
representing basal NO production. Preperfusion of vessels
with NOS inhibitor, L-NMMA (2 mmol/L), for 30 min
followed by the administration of H2O2 in the presence of
L-NMMA completely abolished H2O2-induced NO pro-
duction (n = 4, P < 0.0001). Then Lp was measured under
the same experimental conditions that NO was measured.
The application of L-NMMA nearly abolished H2O2
(10 µmol/L)-induced increases in microvessel Lp with
decrease in mean Lp from 9.3  1.3 to 1.3  0.16 times of
the control after 2-h perfusion of H2O2 (Lp test/Lp contro,
n = 5 per group, P < 0.0001, Fig. 2D).
The effect of H2O2 on EC [Ca
2+]i was examined in
fura-2 loaded microvessels (n = 5). The mean baseline EC
[Ca2+]i was 80  10.5 nmol/L. Perfusion of venules with
H2O2 (10 µmol/L) did not cause immediate increase in
EC [Ca2+]i. A slow but progressive increase in EC [Ca
2+]i
occurred after 15 min of H2O2 perfusion and reached a
significant increase (207  47.1 nmol/L) from control
levels at 36 min of perfusion (p = 0.004), and plateaued at
436  52.7 nmol/L with H2O2 perfusion for ~84 min
(P < 0.0001 vs. vehicle control, Fig. 2C). The application
of LaCl3, a nonselective divalent cation channel blocker
(50 µmol/L, added 20 min before H2O2 administration
and present throughout the study), prevented H2O2-in-
duced increase in EC [Ca2+]i. The mean EC [Ca
2+]i before
and after 2-hour perfusion of H2O2 in the presence of
LaCl3 were 80  10.5 nmol/L and 96  7.2 nmol/L,
respectively (n = 4, P < 0.0001 vs. H2O2 perfusion alone,
Fig. 2C), indicating Ca2+ influx to be the main source for
H2O2-induced increases in EC [Ca
2+]i. Blocking Ca
2+
influx by LaCl3 also prevented H2O2 (10 µmol/L)-induced
delayed increases in Lp (n = 4 & 5 per group, P < 0.0001,
Fig. 2D), indicating the increased EC [Ca2+]i after reaching
certain threshold levels (>300 nmol/L, i.e., at least after 1h
of H2O2 perfusion) to be responsible for increased Lp.
Since H2O2-induced NO production is immediate and
EC [Ca2+]i did not increase until 15 min later, we predict
that, if they are related, the delayed increase in EC [Ca2+]i
could be the result of the initial large amount of NO pro-
duction in H2O2-perfused vessels. To test this relation-
ship, we measured EC [Ca2+]i after blocking NO
production using L-NMMA in four vessels. L-NMMA
(2 mmol/L), without affecting the baseline EC [Ca2+]i
(67  7.8 vs. 75  10.8 nmol/L), completely abolished
H2O2-induced increase in EC [Ca
2+]i (Fig. 2C), indicating
a causal relationship between H2O2-induced excessive NO
and the subsequent Ca2+ influx and eventually Ca2+ over-
load in ECs lining microvessel wall.
H2O2 induced NO-dependent tyrosine
nitration in intact venules
To examine whether ONOO plays a role in H2O2-in-
duced increases in microvessel Lp, we examined nitroty-
rosine, a biomarker of ONOO, in H2O2-perfused
venules. In contrast to the low fluorescence signal in albu-
min-Ringer-perfused vessels (Fig. 3A left panel), H2O2
perfusion (10 µmol/L for 2 h) induced an extensive tyro-
sine nitration in the cytosol and cell membrane (Fig. 3A
middle panel). Arrows indicate the nucleus of ECs with-
out nitrated tyrosine formation. Importantly, L-NMMA
(2 mmol/L) significantly attenuated the nitrated tyrosine
signal (Fig. 3A right panel. The fluorescence intensity (FI)
was quantified in each vessel and summarized in Fig 3B.
The mean FI in vessels with 2-h H2O2 perfusion was
4.8  0.27 times that of the control (n = 4, P < 0.0001),
and the application of L-NMMA before and during H2O2
perfusion (2 h) reduced the FI to 1.3  0.1 times to that
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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of the control (n = 3, P < 0.0001), indicating H2O2-in-
duced ONOO formation is NO dependent.
H2O2 induced superoxide production in
intact venules
NO reacts quickly with superoxide to form ONOO. To
examine the role of H2O2-induced NO in the formation
of ONOO, we examined the intracellular superoxide
levels in H2O2-perfused vessels with DHE staining. As
shown in Fig. 4A, a marked increase in the DHE FI was
observed in both endothelium and pericytes after 30-min
perfusion of H2O2 (10 µmol/L), which was abolished by
pretreatment of the vessels with an inhibitor of NADPH
oxidase, diphenylene iodonium (DPI, 20 µmol/L,). The
mean FIs of DHE were 48  2.5, 141  15.6, and
59  0.5 AU in BSA-Ringer (control, n = 6), H2O2
(n = 5), and H2O2 plus DPI-perfused vessels (n = 6),
respectively (Fig. 4B. P < 0.0001, H2O2 group vs. control
and H2O2 plus DPI group, respectively).
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Figure 2. Causal relationship between H2O2-induced eNOS-derived NO production, increased EC [Ca
2+]i, and microvessel Lp. (A) Summary
results of H2O2-induced time-and dose-dependent increases in microvessel Lp (n = 4–9 vessels per group). (B) H2O2 (10 µmol/L) perfusion
induced a large amount of NO production that was inhibited by L-NMMA (2 mmol/L, administered 30 min before H2O2 perfusion and present
throughout the experiment). Ringer solution containing 1% BSA was used as vehicle control (n = 4 vessels per group). (C) H2O2 (10 µmol/L)
perfusion induced delayed and progressive increases in EC [Ca2+]i. The application of L-NMMA (2 mmol/L) or LaCl3 (50 µmol/L) before and
during H2O2 perfusion prevented the H2O2-induced increases in EC [Ca
2+]i (n = 4 per group). (D) L-NMMA (2 mmol/L, n = 5) and LaCl3
(50 µmol/L, n = 4) prevented the H2O2-induced delayed increases in microvessel Lp (Lp was measured after H2O2 perfusion for 2 h, n = 5).
One-way ANOVA with Tukey post hoc test were used for comparison between groups and paired t-test was used for paired measurements
conducted in the same vessel (A and D). Two-way ANOVA with Tukey post hoc test were used for comparison of data between groups at the
same time points (B and C), ****P < 0.0001. ***P < 0.001, **P < 0.005, *P < 0.05, ns P ≥ 0.6
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Role of ONOO in H2O2-induced increases in
microvessel Lp and endothelial [Ca2+]i
To examine whether NO-derived ONOO accounts for
the H2O2-induced increases in EC [Ca
2+]i and microvessel
Lp, the effects of H2O2 on EC [Ca
2+]i and microvessel Lp
were investigated with the application of uric acid, a
ONOO scavenger. Uric acid (50 µmol/L) perfusion for
20 min did not alter the baseline EC [Ca2+]i (69  4.7
vs. 85  4.1 nmol/L) and Lp (2.3  0.34 vs.
2.5  0.19 9 10-7 cm s1 cmH2O1, P > 0.8, n = 4 for
each group), but significantly reduced H2O2-induced
increase in EC [Ca2+]i from a mean peak value of
403  43.0 (n = 5) to 139  30.6 nmol/L (n = 4,
P = 0.002), and completely prevented the H2O2-induced
increase in Lp (Lptest/ Lpcontrol) from 9.3  1.34 (n = 5)
to 1.0  0.08 times the control level (n = 4, P = 0.003).
All values are compared after 2-h perfusion of H2O2
(10 µmol/L). Fig. 5A,B show the representative experi-
ments and Fig. 5C shows the results summary.
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Figure 3. H2O2 induced NO-dependent tyrosine nitration in
microvessels. (A) Representative confocal images showing the
fluorescent immunostaining of nitrotyrosine in vessels perfused with
control (Ringer solution containing 1% BSA, left), H2O2 (10 µmol/L,
middle), and H2O2 in the presence of L-NMMA (2 mmol/L, right).
(B) Summarized mean FI of nitrotyrosine staining in each group
(n = 3-4 per group, ****P < 0.0001, ns P = 0.55 (One-way
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Figure 4. Superoxide production in H2O2-perfused vessels. (A)
Representative confocal images showing DHE staining is minimum
in a control vessel (left panel), but markedly increased in the nuclei
of both ECs (vertically orientated, indicated by arrows) and
pericytes (horizontally orientated, indicated by arrow heads) after
H2O2 (10 µmol/L) perfusion for 30 min (middle panel). Preperfusion
of vessels with DPI (20 µmol/L) abolished H2O2-induced superoxide
production (right panel). Each image is the projection of the lower
half of the vessel image stack with 0.5 µm per section. The dotted
lines were used to outline the vessel walls. (B) Summarized mean FI
of DHE in control (n = 6), H2O2 (n = 5) and H2O2 with DPI
perfused vessels (n = 6). ****P < 0.0001, ns P = 0.52 (One-way
ANOVA with Tukey post hoc test)
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Peroxynitrite induced delayed and
progressive increases in microvessel Lp in a
dose- and time-dependent manner, a
pattern similar to that observed in H2O2-
perfused vessels
To investigate the direct effect of ONOO on microvessel
permeability, we perfused ONOO to microvessels and
measured the changes in Lp. The mean baseline Lp was
2.1  0.16 9 107 cm s1 cmH2O1 (n = 25). No
changes in Lp were observed with ONOO perfusion for
30 min at 10 and 50 µmol/L (Lptest/Lpcontrol was
1.0  0.02 and 1.0  0.03, respectively, n = 3 per group,
Fig. 6A,D). However, extending the perfusion duration to
1 and 2 h resulted in time- and dose-dependent Lp
increases similar to that observed in H2O2-perfused ves-
sels (Fig 2A). Lp increased significantly to 2.8  0.45
(P = 0.03) and 5.9  0.44 (P = 0.003) times the control
at 10 µmol/L, and to 6.0  0.57 and 12.0  0.96 times
the control at 50 µmol/L (P < 0.001) after 1 and 2 h of
ONOO perfusion, respectively (Fig. 6B,D, n = 4-6 per
group). We also examined the effect of degraded perox-
ynitrite on microvessel Lp in two vessels. No changes in
Lp were observed after 1-h perfusion of degraded perox-
ynitrite (50 µmol/L). Fig 6C represents the contrast of the
Lp changes in peroxynitrite- and degraded peroxynitrite-
perfused vessels.
Peroxynitrite-induced progressive increases
in EC [Ca2+]i contributed to the increases in
microvessel Lp
The causal relationship between ONOO and EC [Ca2+]i
was further examined in seven vessels loaded with fura-2.
Baseline EC [Ca2+]i was 82  12.0 nmol/L. A significant
increase in EC [Ca2+]i occurred at 20  4.0 min of
ONOO perfusion (50 µmol/L), and progressively
reached to a sustained level of 375  30.0 nmol/L at
78  2.3 min of ONOO perfusion (n = 4, Fig. 7A). No
changes in EC [Ca2+]i were observed on vessels perfused
with albumin-Ringer for 1 h (n = 3, data not shown).
Preperfusion of vessels with LaCl3 (50 µmol/L) for
20 min did not affect baseline EC [Ca2+]i, but prevented
ONOO-induced increases in EC [Ca2+]i (the mean EC
[Ca2+]i was 98  15.2 nmol/L at 80 min of ONOO per-
fusion (n = 3, P = 0.0027, Fig. 7A), indicating the role of
Ca2+ influx in ONOO-induced increase in EC [Ca2+]i.
The role of Ca2+ influx in ONOO-induced Lp
increase was then examined. The application of LaCl3
prevented the increased Lp in ONOO (50 µmol/L, 1 h)-
perfused vessesls. The Lptest/Lpcontrol reduced from
6.0  0.57 (n = 6) to 1.1  0.18 times the control
(n = 4, P = 0.0002, Fig. 7B), indicating that the sustained
increase in EC [Ca2+]i to be responsible for ONOO
-in-
duced Lp increase.
Peroxynitrite induced eNOS activation and
NO production and Ca2+ influx dependency
To evaluate the relationship between ONOO and eNOS
activity, NO was measured in ONOO (50 µmol/L)-
0
100
200
300
400
500
600
0
5
10
15***
ns
nsEC
[C
a2
+ ]
i(
nm
ol
/L
)
L p
test / Lp
control
**
Control H2O2 2 h Uric Acid Uric acid+H2O2 2 h
0 
2 
4 
6 
8 
10 
0 10 20 30 40 50 60 
B
A
Ctrl Uric acid Uric acid + H2O2
Lp
 tes
t /L
p c
on
tro
l
Time (min)
2 
h 
pe
rfu
si
on
C
0
100
200
300
400
0 20 40 60 80 100 120 140 160 180 200
Time (min)
E
C
 [C
a2
+ ] i
(n
m
ol
/L
)
Ctrl Uric acid
H2O2
Figure 5. Role of ONOO in H2O2-induced increases in EC [Ca
2+]i
and microvessel Lp. (A and B) Two representative experiments
showing that the application of uric acid (50 µmol/L), a ONOO
scavenger, prevented H2O2-induced increases in microvessel Lp and
EC [Ca2+]i. Uric acid was added 20 min before and throughout the
2-h H2O2 perfusion. C) Summarized results of EC [Ca
2+]i (left y axis)
and Lp (right y axis). n = 4-5 per group. ***P = 0.001,
**P  0.003, ns P ≥ 0.6. (Paired t-test or one-way ANOVA were
used for treatments conducted in the same vessel; and unpaired t-
test with Welch’s correction was used for data comparison
between two groups)
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perfused vessels (n = 4). Perfusion of vessels with
ONOO induced an immediate increase in NO produc-
tion with an initial peak rate at 31.9  6.43% min-1 for
2 min followed by a rate of 6.5  2.30% min-1 till
10  1.4 min (Fig. 8C). This initial increase in FIDAF
(DFI%) was 332  25% of baseline control. With contin-
uous ONOO perfusion, a second peak of NO produc-
tion occurred at ~18 min with a rate of 16.6  4.50%
min-1 and fell to 1.9  0.10% min1 at ~ 62 min
(Fig. 8C). This second phase of FI increase (DFI%) was
222.0  18.50% of the control (Fig. 8A,B). Control
experiments in vessels perfused with albumin-Ringer solu-
tion (n = 3) only showed basal NO production at a rate
of 0.1%/min (Fig. 8A,B).
By comparing ONOO-induced NO production with
the time course of the increases in EC [Ca2+]i, we found
that the initial increase in NO production occurred in
the absence of increased EC [Ca2+]i, whereas the second
phase of NO production occurred concomitantly with
increases in EC [Ca2+]i (Fig. 8C). To examine the role
of Ca2+ influx in ONOO-induced NO production, NO
was measured on four vessels pretreated with LaCl3
(50 µmol/L). As described above (Fig. 7A), LaCl3 pre-
vented ONOO-induced increases in EC [Ca2+]i. Under
the same experimental conditions as those EC [Ca2+]
were measured, NO measurements showed that inhibi-
tion of Ca2+ influx by 3 had no effect on the ONOO-in-
duced initial NO production, but attenuated the second
phase of NO production (DFI% reduced from
222.0  18.50% to 15.0  3.25% of control, Fig. 7B,C).
These data suggest that ONOO-induced initial NO
does not require increased Ca2+ influx, but the second
phase of NO production was initiated by the increased
EC [Ca2+]i.
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We also examined whether ONOO-induced NO pro-
duction was a result of NOS activation. Treatment of ves-
sels with NOS inhibitor, L-NMMA (2 mmol/L), 20 min
before and during ONOO perfusion significantly
decreased ONOO-induced NO production. FIDAF
reduced from 570  141.0% to 154  50.0 % of control,
(n = 4, Fig. 8B).
Discussion
Our study, using quantitative measurement of microvessel
permeability in combination with fluorescence and
confocal microscopy, identified a novel mechanism by
which H2O2, a commonly known reactive oxygen species
essential for the pathogeneses of cardiovascular diseases,
interplays with superoxide, eNOS-derived NO, and
ONOO, leading to EC Ca2+ overload, vascular cell dam-
age, and barrier dysfunction in intact vessels. H2O2 at a
pathophysiological relevant concentration (10 µmol/L)
(Lacy et al., 2000; Banerjee et al., 2003) induced eNOS
activation with a large amount of NO production. Instead
of causing an immediate increase in microvessel perme-
ability that occurred in PAF or other inflammatory medi-
ator-stimulated microvessels (He et al., 1996; Zhu and
He, 2005; Zhou and He, 2010), this large amount of NO
(~10 times the amount of NO detected in PAF-perfused
microvessels) was shown to be responsible for intracellu-
lar Ca2+ accumulation, subsequent cell apoptosis, and the
delayed and progressive increases in microvessel perme-
ability ( Zhou et al., 2013). Concomitant with the exces-
sive NO production, a marked production of superoxide,
as well as extensive protein tyrosine nitration, a biomar-
ker for ONOO, were detected in H2O2-perfused vessels,
indicating H2O2-induced ONOO
 formation in intact
microvessels. Functionally, H2O2-induced increases in
microvessel Lp was prevented by pretreatment of the ves-
sels with uric acid, a strong ONOO scavenger, suggest-
ing a causal relationship between ONOO and H2O2-
induced microvessel barrier dysfunction. The direct evi-
dence of the role of ONOO in H2O2-induced vascular
barrier dysfunction was demonstrated by exogenously
applied peroxynitrite to the microvessels, which showed a
dose- and time-dependent increase in microvessel Lp, a
pattern similar to that observed in H2O2-perfused vessels.
Importantly, ONOO, a downstream product derived
from NO, is demonstrated to cause further eNOS activa-
tion and NO production. This reciprocal interaction
between H2O2, ONOO

, and eNOS constitutes a self-pro-
moted amplification of ONOO. Taken together, this
study provides the first in vivo evidence that ONOO,
derived from H2O2-induced NO and superoxide, further
activates eNOS, leading to a self-promoted amplification
of signaling cascades, resulting in H2O2-induced
ONOO-mediated cell damage and microvessel barrier
dysfunction. Details are illustrated in Fig. 9.
Role of eNOS-derived NO production in the
regulation of H2O2-induced microvessel
barrier dysfunction
Previous studies from our laboratory and others have
demonstrated that eNOS-derived excessive NO plays an
essential role in inflammatory mediators-induced vascular
leakage (Mayhan, 1992; Yuan et al., 1993; He et al., 1997;
Hatakeyama et al., 2006; Zhou and He, 2010; Zhou and
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Figure 7. ONOO-induced Ca2+ influx contributes to increased
microvessel Lp. (A) The time course of the changes in EC [Ca2+]i
when vessels were perfused with ONOO (50 µmol/L) in the
absence (n = 4) or presence of LaCl3 (50 µmol/L, N = 3). Perfusion
of ONOO induced delayed and progressive increases in EC [Ca2+]i
and the application of LaCl3 that blocked Ca
2+ influx prevented
such effect. Arrow indicates the initiation of ONOO perfusion. (B)
Summarized results of ONOO-induced Lp increase and its
dependency on Ca2+ influx demonstrated by the effect of LaCl3 on
ONOO-perfused vessels. *P < 0.05, **P = 0.0027, ***P < 0.0005,
ns P = 0.6
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He, 2011). A typical inflammatory mediator-induced
increase in microvessel permeability usually is immediate
and transient, which is associated with the transient for-
mation of endothelial gaps between adjacent ECs (Majno
and Palade, 1961; Wu and Baldwin, 1992; Baluk et al.,
1997; Jiang et al., 2008; Zhou and He, 2011). In contrast
to the inflammatory mediator-induced immediate and
transient increase in microvessel permeability, H2O2
caused a delayed and progressive increase in microvessel
Lp in a dose- and time-dependent manner (Zhou et al.,
2009; Zhou et al., 2013), indicating the involvement of
different mechanisms. Our study demonstrated that H2O2
at pathophysiologically relevant concentrations (10 µmol/
L) induce both Ca2+-independent and -dependent eNOS
activation and the excessively produced NO triggers cas-
pase activation and the impairment of intracellular Ca2+
homeostasis, leading to vascular cell apoptosis and conse-
quently delayed and progressive increases in microvessel
permeability ( Zhou et al., 2013). In this case, the H2O2-
induced initial NO production in the absence of increased
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Figure 8. ONOO induced Ca2+influx-independent and -dependent eNOS activation and NO production in perfused venules. (A) Representative
DAF-2 fluorescent images in one individual vessel showing the changes in FIDAF-2 at selected time points upon ONOO
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EC [Ca2+]i, although being five times more than that
observed in PAF-perfused vessels, did not cause immedi-
ate increase in microvessel permeability (Zhu and He,
2005; Zhou and He, 2010). These findings suggest that
the excessive NO-mediated vascular barrier dysfunction
may depend on the activation of other concurrent signal-
ing pathways, such as increased EC [Ca2+]i, or the loca-
tion of NO production (Sanchez et al., 2006), thus the
pattern of NO-mediated increase in microvessel perme-
ability is stimulus specific.
Our previous study illustrated that the H2O2-induced
initial phase of eNOS activation is predominantly through
increased phosphorylation at Ser1177 independent of ele-
vated EC [Ca2+]i, whereas the second phase of eNOS acti-
vation is mainly triggered by increased EC [Ca2+]i and
Ca2+/CaM binding (inhibited by caveolin-1, CAV-1),
coordinated with decreased phosphorylation at Thr495
(Zhou et al., 2013). Thus, not only does the delayed
increases in EC [Ca2+]i contribute to EC Ca
2+ overload, it
also triggers a second phase of Ca2+-dependent NO pro-
duction, further amplifying the NO-dependent signaling
cascade. This notion is supported by the fact that block-
ing NOS activation by L-NMMA prevented the delayed
and progressive increases in EC [Ca2+]i (Fig. 2C). The
sustained increase in EC [Ca2+]i, an indication of
impaired Ca2+ homeostasis, appears to be essential for
vascular cell apoptosis and subsequently increased
microvessel permeability.
Role of NO-derived ONOO in H2O2-induced
increases in microvessel Lp
Although NO has been reported to have potential cyto-
toxic effects, many of them are attributed to its oxidation
product, particularly ONOO rather than NO itself (Xia
et al., 1996; Riobo et al., 2001; Pacher et al., 2007). NO
reacts rapidly with superoxide to form ONOO, a strong
oxidant, capable of oxidizing and nitrating lipid, protein,
and DNA, resulting in cell death and tissue injury (Radi
et al., 1991; Pacher et al., 2007; Szabo et al., 2007). Con-
sistent with this concept, our results support that H2O2-
induced excessive NO-derived ONOO is the key con-
tributing to increased microvesel permeability in intact
rat venules. This conclusion is supported by the following
evidence: (1) H2O2 induced concomitant NO and super-
oxide production, the two elements required to form
ONOO, (2) H2O2 induced NO-dependent extensive pro-
tein tyrosine nitration (a commonly recognized biomarker
for ONOO) in the vascular wall, (3) uric acid, an
endogenous ONOO scavenger (Ames et al., 1981; Hoo-
per et al., 1998; Tsukada et al., 2000; Walford et al., 2004;
Kuzkaya et al., 2005), prevented H2O2-induced impair-
ment of Ca2+ homeostasis and increases in microvessel
permeability; and (4) exogenously applied ONOO
induced a delayed and progressive increases in EC [Ca2+]
and microvessel Lp in a dose- and time-dependent man-
ner, a pattern similar to that observed in H2O2-perfused
vessels.
The H2O2-induced superoxide production has been
considered as an important feed-forward mechanism for
ROS-mediated pathogenesis of cardiovascular diseases
(Cai, 2005). In vitro studies showed that inhibition of
p22phox by siRNA and knockout of gp91phox (the two
transmembrane subunits of NAD(P)H oxidase) prevented
the H2O2-induced increases in superoxide production in
vascular endothelial cells (Li et al., 2001; Djordjevic et al.,
2005). Using confocal microscopy, we detected a ~three-
fold increase in DHE FI in the nuclei of both ECs and
pericytes as early as 30 min of H2O2 perfusion, indicating
a large amount of superoxide production (Fig. 4). Within
the same period, NO production increased ~eightfold
Figure 9. Schematic diagram illustrating the mechanisms of H2O2-
induced microvessel barrier dysfunction. H2O2 at pathophysiological
levels activate eNOS and NADPH oxidase in the endothelium and
pericytes, leading to increased formation of NO and O2
. The
temporal and spatial proximity of largely produced NO and O2

promote the formation of ONOO, a more potent oxidant, leading
to ONOO-mediated lipid peroxidation, protein tyrosine nitration,
subsequent impairment of intracellular Ca2+ homeostasis, and
vascular cell apoptosis. Both NO-derived ONOO and the delayed
increases in EC [Ca2+]i are able to further activate eNOS, resulting
in amplified NO production and NO-dependent downstream
cascade. These positive feedback loops, indicated by red dotted
lines, play an important role in sustained production of ONOO,
and eventually ONOO-mediated endothelial cell Ca2+ overload,
vascular cell apoptosis, and progressively increased microvessel
permeability. The application of inhibitors (shaded boxes) blocks the
downstream events. This diagram include both previous (Zhou
et al., 2009; Zhou et al., 2013) and current studies. DPI
(diphenylene iodonium, NADPH oxidase inhibitor); eNOS:
endothelial nitric oxide synthase; CAV-1: Caveolin-1 (eNOS
inhibitor); z-VAD-FMK: caspase inhibitor
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(indicated by the increased FIDAF-2, Fig. 2B). When both
NO and superoxide are produced in close proximity, a
spontaneous ONOO formation is expected in the H2O2-
perfused vessels. Our results that DPI, a commonly used
NAD(P)H oxidase inhibitor, prevented the increases in
superoxide production in both endothelium and pericytes
in H2O2-perfused intact vessels (Fig. 4) support NAD(P)
H oxidase as the primary source for the H2O2-induced
superoxide production.
More direct evidence of H2O2-induced ONOO
 forma-
tion is the extensive NO-dependent tyrosine nitration
detected after 2-h H2O2 perfusion (Fig. 3). Nitrotyrosine
has been recognized as an important biomarker for
ONOO and an indication of systemic nitroxidative stress
(Prutz et al., 1985; Reiter et al., 2000; Radi, 2004; Radi,
2013).
The application of uric acid, an endogenous ONOO
scavenger (Hooper et al., 1998; Tsukada et al., 2000; Wal-
ford et al., 2004; Kuzkaya et al., 2005), that abolished the
H2O2-induced increases in EC [Ca
2+]i (Fig. 5B,C) and
microvessel Lp (Fig. 5A,C) further support a role of
ONOO in H2O2-mediated changes in microvessels. Fur-
thermore, the direct perfusion of ONOO in microvessels
showed delayed and progressive increases in both EC
[Ca2+]i and microvessel Lp in a dose- and time-dependent
manner (Fig. 6), a similar pattern to that observed in
H2O2-perfused vessels (Zhou et al., 2009; Zhou et al.,
2013), and inhibition of Ca2+ influx with LaCl3 prevented
Ca2+ accumulation in ECs and the increased Lp in perox-
ynitrite-perfused vessels (Fig. 7). These results demon-
strate a direct role of ONOO in the impairment of Ca2+
homeostasis and vascular barrier dysfunction.
Interaction between ONOO and eNOS-
derived NO production: a self-promoted
amplification, contributing to ONOO-
mediated vascular damage and barrier
dysfunction
Currently, the role of ONOO in eNOS activity, particu-
larly under in vivo conditions, remains unknown. While
some early studies reported that ONOO induced coro-
nary vasodilation in isolated rat hearts and coronary arte-
rial rings of dogs through increased NO production (Liu
et al., 1994; Villa et al., 1994), other studies on cultured
bovine ECs indicated that ONOO-induced eNOS phos-
phorylation at Ser1179 (corresponding to Ser1176 in human
and rats) increased O2
-.production, rather than that of
NO (Zou et al., 2002; Zou et al., 2002). Using quantita-
tive fluorescent imaging in intact venules, our study
demonstrated that ONOO induced a large amount of
NO that was abolished by L-NMMA, indicating eNOS-
derived NO production (Fig. 7). Similar to what have
been observed in H2O2-perfused vessels (Shen et al.,
1998), ONOO induced two phases of eNOS-derived NO
production. As shown in Fig. 8C, the initial NO produc-
tion with a higher peak rate occurred in the absence of
increases in EC [Ca2+]i, whereas the second phase NO
production is slow and concomitant with progressively
increased EC [Ca2+]i. Blockade of Ca
2+ influx by LaCl3
did not affect the initial NO production, but abolished
the NO production in the second phase (Fig8B,C), sug-
gesting that peroxynitrite-induced initial eNOS activation
is independent on Ca2+ increase, whereas the second
phase of eNOS activation is Ca2+ dependent. This inter-
esting finding suggests that ONOO, a downstream pro-
duct formed by NO and superoxide, further amplified
NO production, resulting in an amplification of NO-de-
pendent signaling and augmented ONOO-mediated vas-
cular cell damage and barrier dysfunction.
Methodology assessment
Vascular barrier function is usually referred to vascular per-
meability to both fluid and solutes. In this study, microvas-
cular permeability is determined by measuring hydraulic
conductivity, Lp, one of the three permeability coefficients
that assesses the transport of fluid. Although microvessel
permeability to different sizes of solute was not measured,
experimental evidence showed that Lp well correlates with
the transports of small- to intermediate-sized molecules
(Michel and Curry, 1999). Importantly, most of the
increases in solute flux (including large molecules) are cou-
pled to water flows. When permeability increases, the mag-
nitude changes in fluid or small molecules could be
different from macromolecules, depending on transport
pathways involved, they usually followed the same time
course as the changes in Lp (Rutledge et al., 1990; Rutledge
et al., 1995; Michel and Curry, 1999). The permeability
coefficients are more quantitative and accurate measures of
vascular wall properties than the commonly used flux or
leaky sites, since they are not affected by unknown varia-
tions of hemodynamic factors and surface area for trans-
port (Michel and Curry, 1999). Importantly, all the studies
presented here were conducted in individually perfused
intact microvessels under well-controlled conditions, and
the changes in NO, superoxide, ONOO, and EC [Ca2+]i
were all measured under the same experimental conditions
similar to those where Lp was measured, which enabled us
to directly correlate the changes in signaling pathways with
microvessel permeability.
Another advantage of using individually perfused vessel
to investigate the effects of reactive reagents is that the
solution containing H2O2 or ONOO
 in the perfusion
pipette constantly refreshes the perfusate in the vessel
lumen, which provides a relatively constant concentration
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of H2O2 or ONOO
 to the cells lining vascular walls.
This constantly refreshed perfusate makes a fundamental
difference from the one time addition of reactive reagents
to the tissue or cell culture medium that results in an
immediate reaction of the reactive agents with the cells
and other components in the medium and lost it activity
quickly. In those studies, usually hundreds of µmol/L or
mmol/L concentrations of peroxide (far more than the
pathological concentrations detected in the plasma) were
used in order to show some of the responses (Alexander
et al., 2000; Kevil et al., 2000; Lee et al., 2006; Jin et al.,
2012; Suresh et al., 2015). We also knew that H2O2 or
ONOO even reacts with marker cells (about 1% RBCs)
in the perfusate and affects the effectiveness of the treat-
ment. That is why we perfuse the vessel without marker
cells for a certain time period and only add the marker
cells during Lp measurements. This also explains why we
can get the responses with pathological range of plasma
H2O2 concentrations (10 µmol/L). Based on our current
(Figs 2, 6, 7) and previous studies (He et al., 1996; Zhou
et al., 2013), the cell marker-free perfusate in the presence
of 1% BSA is able to well maintain the baseline Lp, EC
[Ca2+]i and basal NO up to 2-h perfusion period which
we have tested.
Compared to normal blood, our perfused vessels lack
blood cells, plasma SOD, catalase, and substances released
from blood cells, which could affect the production of
ROS, reactive nitrogen species (RNS), and NO. Under dis-
eased conditions, measured plasma peroxide levels are close
to 10 µmol/L (Lacy et al., 2000). We consider that the
detected plasma H2O2 level is the effective level of peroxide
that affects endothelial cells lining the vascular walls and is
the net balance of the constant production of ROS and its
reaction with plasma enzymes such as SOD and catalase in
the vasculature. Our experimental conditions bypassed the
constant ROS production and catalytic processes when
blood is circulating in the vasculature, and applied this
pathologically relevant net plasma H2O2 concentration to
the vessel lumen, which allows us to investigate its direct
effect on vascular walls and avoid other confounding
factors.
The use of DHE to detect intracellular formation of
superoxide has been assessed and characterized by many
studies. The formation of 2-hydroxyethidium is consid-
ered as the specific reaction of DHE with superoxide and
not with other biologically relevant oxidants, which can
be separated from its parent DHE and ethidium (Zie-
lonka et al., 2008), including vessel segment studies and
confirmed with high performance liquid chromatography
(HPLC, Dikalov et al. (2007)). The advantage of using
the DHE fluorescence imaging in our perfused intact ves-
sels is its ability to provide spatial detection of superoxide
production at vascular walls using the same experimental
approach where other signaling changes and microvessel
permeability are measured, which could not be achieved
with other methods. The pharmacological inhibitors used
in this study such as DPI and uric acid showed consistent
results as NADPH oxidase inhibitor and ONOO scav-
enger (Hooper et al., 1998; Kean et al., 2000; Kim et al.,
2018; Pietruczuk et al., 2019), respectively, even though
they may have nonspecific effects. These additional sup-
porting evidence, together with the results of DHE stain-
ing and the nitrotyrosine immunostaining provided
multiple lines of evidence to support the H2O2-induced
superoxide production and subsequent ONOO forma-
tion.
One potential concern is the specificity of using DAF-2
to measure NO in the presence of the reactive oxidants
(Jourd’heuil, 2002). DAF-2 DA has been used to measure
intracellular NO in a wide range of biological systems.
However, since the interaction of DAF-2 with NO to
form DAF-2 triazole form (DAF-2T, high fluorescence
product) requires the presence of O2, it raises concerns
about the potential effects of oxidants on DAF-2T conver-
sion (Jourd’heuil, 2002; Wardman, 2007; Hall and Garth-
waite, 2009). To address this issue, we have carefully
characterized this NO probe in individually perfused ves-
sels and demonstrated the cautious procedures to avoid
non-NO-related DAF-2 FI (Zhou and He, 2011). We also
assess the specificity of DAF-2 by measuring its direct
reaction with H2O2, superoxide (generated by HX/XO),
and ONOO in solution using the same imaging system
when NO was measured in intact microvessels. The
results shown in Fig 1 demonstrated that DAF-2
(10 µmol/L, closer to intracellular DAF-2 concentration
when 5 µmol/L DAF-2 DA was used to load vessels) does
not directly interact with ROS and ONOO in the
absence of NO within the reagents’ concentrations we
used in the experiments, although at this point we may
not exclude the possibility that the presence of oxidants
may facilitate the DAF-2T formation with increased flux
of NO and enhance DAF-2 FI. Our results show that the
use of NOS inhibitor completely blocked the H2O2- or
ONOO-induced increases in DAF-2 FI indicating a
strong association between DAF-2T and increased NO
production. We consider that DAF-2 is the most reliable
specific NO indicator comparing with other up to date
methods. Since the H2O2- and ONOO
-induced DAF-2
FI changes are in large magnitude, some contributions
from oxidant effect will not change the nature of our
findings. Especially, our previous studies have provided
the validation of the NO measurements with DAF-2 by
conducting parallel studies with immunostaining of eNOS
activation (Zhou et al., 2013).
In conclusion, our study uncovered a novel mechanism
of elevated H2O2-mediated microvascular dysfunction
2019 | Vol. 7 | Iss. 16 | e14206
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that commonly occurs in many cardiovascular diseases.
H2O2 at pathophysiologically relevant concentrations,
induces a large amount of eNOS-derived NO concomi-
tant with increased superoxide production, and subse-
quent formation of ONOO, a more potent reactive
nitrogen species (RNS). The formed ONOO is able to
further activate eNOS and augment NO production,
resulting in a self-promoted augmentation of nitroxidative
stress and subsequent vascular cell damage and vascular
barrier dysfunction. The signaling cascades and sequential
functional changes illustrated in Fig. 9 offer novel insight
into ROS and/or RNS-mediated pathogenesis of cardio-
vascular diseases.
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